Want to get out of your comfort zone and into an adrenaline rush? Our friends at First Descents (FD) provide free, life-changing outdoor adventures for young adults (ages 18-45) living…
Read More
The U.S. Food and Drug Administration has approved Briumvi (ublituximab) as a disease-modifying therapy for adults with relapsing forms of MS. And as of late January, this DMT is now commercially…
There are now several generic versions of the common MS drug Gilenya approved for use in the United States. Patients currently taking Gilenya should be aware that this could impact…
This webinar is designed to provide information and insight into helpful tips on how to manage your independence, endurance and adaptions at home and in the workplace. (Recorded January 31,…
A multiple sclerosis diagnosis can complicate a lot of future plans, especially for people who may be beginning to think about starting or growing their families. In this…
Welcome to a very special edition of Conversations on MS! This session features three MS-specialist neurologists answering frequently asked questions. Dr. John Corboy moderates the event. Corboy is the Medical…
The MS Center’s Tom Stewart, M.S., PA-C, J.D. presents an informative webinar on two important topics for Colorado residents. Stewart provides a review of Colorado’s new paid Family Medical…
We are saddened to share that Dr. Jack Burks passed away on November 18, 2022. Dr. Burks was a core founder of the Rocky Mountain MS Center, and was at…
NfL and GFAP as Measures of Disease Progression Prospective study to evaluate Neurofilament Light (NfL) and glial fibrillary acidic protein (GFAP) as biomarkers for disease progression over time in patients…
Biomarkers are biological markers that can be used in diagnosis, selecting treatments, and evaluating treatment responses. Having pre-collected samples is invaluable for this research, and the Biobank ensures that researchers…